225/250 28 ARTICLE: 4729/5000 29 ABSTRACT Simian hemorrhagic fever virus (SHFV) causes a fulminant and typically 30 lethal viral hemorrhagic fever (VHF) in macaques (Cercopithecinae: Macaca spp.) but 31 causes subclinical infections in patas monkeys (Cercopithecinae: Erythrocebus patas). 32 This difference in disease course offers a unique opportunity to compare host-33 responses to infection by a VHF-causing virus in biologically similar susceptible and 34 refractory animals. Patas and rhesus monkeys were inoculated side-by-side with SHFV. 35 In contrast to the severe disease observed in rhesus monkeys, patas monkeys 36 developed a limited clinical disease characterized by changes in complete blood counts, 37 serum chemistries, and development of lymphadenopathy. Viremia was measurable 2 38 days after exposure and its duration varied by species. Infectious virus was detected in 39 terminal tissues of both patas and rhesus monkeys. Varying degrees of overlap in 40 changes in serum concentrations of IFN-γ, MCP-1, and IL-6 were observed between 41 patas and rhesus monkeys, suggesting the presence of common and species-specific 42 cytokine responses to infection. Similarly, quantitative immunohistochemistry of terminal 43 livers and whole blood flow cytometry revealed varying degrees of overlap in changes in 44 macrophages, natural killer cells, and T-cells. The unexpected degree of overlap in 45 host-response suggests that relatively small subsets of a host's response to infection 46 may be responsible for driving pathogenesis that results in a hemorrhagic fever. 47 Furthermore, comparative SHFV infection in patas and rhesus monkeys offers an 48 experimental model to characterize host-response mechanisms associated with viral 49 hemorrhagic fever and evaluate pan-viral hemorrhagic fever countermeasures. 50 IMPORTANCE Host-response mechanisms involved in pathogenesis of VHFs remain 51 poorly understood. An underlying challenge is separating beneficial, inconsequential, 52 and detrimental host-responses during infection. The comparison of host-responses to 53 infection with the same virus in biologically similar animals that have drastically different 54 disease manifestations allows for the identification of pathogenic mechanisms. SHFV, a 55 surrogate virus for human VHF-causing viruses likely causes subclinical infection in 56 African monkeys such as patas monkeys but can cause severe disease in Asian 57 macaque monkeys. Data from the accompanying article by Buechler et al. support that 58 infection of macaques and baboons with non-SHFV simarteviruses can establish 59 persistent or long-term subclinical infections. Baboons, macaques, and patas monkeys 60 are relatively closely taxonomically related (Cercopithecidae: Cercopithecinae) and 61 therefore offer a unique opportunity to dissect how host-response differences determine 62 disease outcome in VHFs.
INTRODUCTION
4.27 log10 PFU/mg in axillary lymph nodes. 246 Bone marrow, cerebella, jejuna, axial and inguinal lymph nodes, kidneys, and 247 thyroids were assessed for evidence of SHFV infection by TEM. DMVs and apparently 248 mature virions were found in the jejunum of the SHFV-inoculated patas monkey with the 249 highest terminal viremia (Fig 3C and D) . ISH for SHFV vRNA was performed to assess 250 the livers, spleens, brainstems, cerebella, and femoral bone marrow of SHFV-inoculated 251 subjects for signs of SHFV replication. The liver of 2 SHFV-inoculated patas monkeys 252 and, rarely, the spleen of the third was positive for SHFV vRNA ( Fig 2B) using 253 RNAscope. The femoral bone marrow of the patas monkey with the highest terminal 254 titer was positive for vRNA. vRNA was detected by ISH in the cerebellum, brain-stem, 255 spleen, and liver of all SHFV-inoculated rhesus monkeys. vRNA was detected in 256 femoral bone marrow of all three SHFV-inoculated rhesus monkeys. Morphologically, 257 ISH data support that monocytes and endothelial cells are sites of SHFV infection in 258 examined livers, spleens, brainstems, and cerebella of both SHFV-inoculated patas and 259 rhesus monkeys. In all tissues, cells positive for SHFV vRNA (RNAScope) were 260 morphologically consistent with macrophage-lineage cells; in each of the tissues 261 evaluated these cells were present in fairly low numbers.
262

SHFV infection of patas and rhesus monkeys elicit strong and overlapping
263 immune responses. Quantitative immunohistochemistry (qIHC) revealed statistically 264 significant (t-test, p<0.05) changes in inflammatory cell populations in livers of SHFV-265 inoculated monkeys ( Fig 4A) . On average, SHFV-inoculated patas monkeys had livers 266 with increased CD3 and Iba1 signals when compared to uninfected patas monkeys. compared to uninfected patas monkeys but did not reach significance (p=0.06). CD8 269 and NKG2A signals were increased in SHFV-inoculated rhesus monkeys compared to 270 uninfected controls. In the spleen, significant changes were seen in major 271 histocompatibility complex class-1 (MHC1) and Iba1 signals between SHFV-inoculated 272 and mock-inoculated patas monkeys ( Fig 4B) . No significant differences in cell Mean monocyte chemoattractant protein 1 (MCP-1) concentrations peaked at day 2 288 PI in all SHFV-inoculated patas monkeys and the two non-surviving rhesus monkeys 289 (28.61 and 38.80 group MFC, respectively; 11,477.68 and 8,266.47 pg/ml GMC, respectively) ( Fig 4B) . All SHFV-inoculated rhesus monkeys had a second MCP-1 291 concentration peak at day 8 PI (group MFC: 50.68; GMC: 5,617.24 pg/ml).
292
SHFV-inoculated patas monkeys had mild increases in interleukin 6 (IL-6) 293 concentrations in comparison to their mock counterparts (3.93 and 1.07 mean of 294 individual PI fold changes respectively, 11.04 and 3.97 pg/ml GMC, respectively).
295
SHFV-inoculated rhesus monkeys had increased IL-6 concentrations 2 days PI (group ). The remaining analytes were below the limit of detection and were not considered 299 for further analysis.
300
Flow cytometry of whole blood revealed increased numbers of circulating natural 301 killer (NK) cells in SHFV-inoculated patas monkeys on days 12 and 19 PI ( Fig 5A) . In 302 contrast, SHFV-inoculated rhesus monkeys had a single, larger, increase in circulating 303 NK cells on day 8 PI. Changes in Ki67 + NK cells in SHFV-inoculated patas monkeys 304 were more variable, with one patas monkey reaching peak numbers at 2 days PI and 305 the other two patas monkeys reaching peak numbers of day 8 PI ( Fig 5B) . Increased Ki-306 67 + numbers in the surviving rhesus monkey returned to baseline by the conclusion of 307 the experiment.
308
Circulating CD14 + monocytes were decreased in SHFV-inoculated patas monkeys at 309 day 2 PI prior to returning to baseline counts, whereas counts in SHFV-inoculated 310 rhesus monkeys appeared unchanged throughout the experiment ( Fig 5C) . SHFV-311 inoculated patas and rhesus monkeys had decreased numbers of CD14 + CD163 + 312 macrophages ( Fig 5D) starting at day 2 PI that remained until each subject's respective endpoint. Both SHFV-inoculated patas and rhesus monkeys had declines in circulating 314 CD4 + and CD8 + T-cell numbers starting on day 2 PI, but counts recovered by day 10 PI 315 (data not shown). Numbers of PD-1 + CD8 + T-cells began to increase in both SHFV-316 inoculated patas and rhesus monkeys on day 10 and 8 PI, respectively, and remained 317 elevated until the conclusion of the experiment (Fig 6E) . Ki-67 + CD8 + T-cell numbers 318 were elevated on day 2 PI before decreasing to baseline counts. A second, larger, peak 319 in Ki-67 + CD8 + T-cell numbers was seen on day 8 PI in both SHFV-inoculated patas and 320 rhesus monkeys, followed again by a return to baseline counts ( Fig 5F) .
321
IgG antibody responses were detected by enzyme-linked immunosorbent assay 322 (ELISA) in all three SHFV-inoculated patas monkeys and two of the three (the survivor 323 and one non-survivor) SHFV-inoculated rhesus monkeys (Fig 6) . Two SHFV-inoculated 324 patas monkeys had detectable anti-SHFV antibodies on day 10 PI and the third on day 
